SLC1A3 Is a Novel Prognostic Biomarker Associated with Immunity and EMT in Hepatocellular Carcinoma

Investigators examined the levels of solute carrier family 1 member 3 (SLC1A3) within HCC and its implications on immunological and epithelial–mesenchymal transition features using the TCGA, ImmPort, and Molecular Signatures databases.